J. Lipid Res. Please sign the JLR Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on June 1, 2005

Papers In Press, published online ahead of print March 1, 2005
J. Lipid Res., doi:10.1194/jlr.M500011-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M500011-JLR200v1
46/6/1213    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ching Yin, L.
Right arrow Articles by Genest, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ching Yin, L.
Right arrow Articles by Genest, J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on January 11, 2005
Revised on February 15, 2005
Accepted on February 24, 2005

ESI-MS quantitation of increased sphingomyelin in Niemann-Pick disease type B HDL

Lee Ching Yin, Alain Lesimple, Åsmund Larsen, Orval Mamer, and Jacques Genest

Department of Medicine, McGill University, Montreal, Quebec H3A 1A1

Corresponding Author: jacques.genest{at}muhc.mcgill.ca

HDL have been proposed to have antiatherogenic properties because of their role in reverse cholesterol transport as lipid acceptors. In order to elucidate the phospholipid profile of these particles, we used electrospray ionization mass spectrometry (ESI-MS) to examine the phosphatidylcholine (PC) and sphingomyelin (SM) composition of HDL purified from plasma and nascently generated in vitro from fibroblasts. We also quantitatively compared the phospholipids present in these lipoproteins between normal and Niemann-Pick type B (NPD-B) diseased subjects characterized by sphingomyelinase (SMase) deficiency. We demonstrated that plasma HDL from NPD-B were significantly enriched in SM by an average of 28%, particularly the palmitoyl SM (with an increase of 95%) which accounted for approximately 25-44% of total SM molecular species. Similarly, we observed an increase of approximately 63% in total SM levels in the nascent HDL prepared from NPD-B fibroblasts. While PC levels in nascent HDL were comparable between control and NPD-B cells, there was a 95% increase in the total PC levels similar to that of SM in plasma HDL extracted from NPD-B subjects. These data provide insight into the structure of HDL and identify potential new roles for SMase in lipoprotein metabolism.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
A. Kuksis and W. Pruzanski
Phase composition of lipoprotein SM/cholesterol/PtdCho affects FA specificity of sPLA2s
J. Lipid Res., October 1, 2008; 49(10): 2161 - 2168.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
C. Y. Lee, A. Lesimple, M. Denis, J. Vincent, A. Larsen, O. Mamer, L. Krimbou, J. Genest, and M. Marcil
Increased sphingomyelin content impairs HDL biogenesis and maturation in human Niemann-Pick disease type B
J. Lipid Res., March 1, 2006; 47(3): 622 - 632.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.